Pharma 4.0 Market Growth Outlook Through 2024-2033

Overview and Scope

Pharma 4.0, also known as Pharmaceutical 4.0, refers to the convergence of advanced digital technologies with the pharmaceutical industry, akin to the broader concept of Industry 4.0. It represents a transformative approach to pharmaceutical manufacturing and healthcare delivery, aiming to address rising costs, regulatory compliance, drug shortages, and the need for personalized treatments while unlocking new opportunities for innovation and improving patient care.

Sizing and Forecast
The pharma 4.0 market size has grown exponentially in recent years. It will grow from $14.92 billion in 2023 to $17.99 billion in 2024 at a compound annual growth rate (CAGR) of 20.5%.  The growth in the historic period can be attributed to regulatory compliance and quality assurance, drug patent expirations and generic competition, increasing healthcare expenditure, demand for personalized medicine and biologics, globalization of pharmaceutical markets.

The pharma 4.0 market size is expected to see exponential growth in the next few years. It will grow to $38.44 billion in 2028 at a compound annual growth rate (CAGR) of 20.9%.  The growth in the forecast period can be attributed to shift towards value-based healthcare models, aging population and increased healthcare needs, demand for personalized medicine and precision therapeutics, regulatory reforms and changes in healthcare policies, growing emphasis on patient-centric care and outcomes. Major trends in the forecast period include personalized medicine and precision therapeutics, digital health technologies, value-based healthcare models, regulatory harmonization and accelerated approval processes, supply chain digitization and transparency.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/pharma-4-0-global-market-report

Segmentation & Regional Insights
The pharma 4.0 market covered in this report is segmented –
1) By Component: Hardware, Software, Services
2) By Technology: Cloud Computing, Artificial Intelligence (Al), Big Data Analytics, Internet of Things (IoT)
3) By Application: Drug Discovery And Development, Clinical Trials, Manufacturing
4) By End-User: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs) And Contract Manufacturing Organizations (CMOs)

North America was the largest region in the pharma 4.0 market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma 4.0 market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14772&type=smp

Major Driver Impacting Market Growth
The expansion of telemedicine and remote patient monitoring is expected to propel the growth of the pharma 4.0 market going forward. Telemedicine refers to the practice of providing medical care and consultation remotely using telecommunications technology. Remote patient monitoring involves collecting, transmitting, and analyzing patient health data from a distance using technology-enabled devices and platforms. Telemedicine and remote patient monitoring are expanding due to technological advancements, increasing demand for convenient healthcare access, and the need to manage chronic conditions efficiently. Telemedicine and remote patient monitoring play significant roles in pharma 4.0, facilitating patient-centered care, enabling real-time data collection for personalized medicine, and enhancing pharmaceutical companies' ability to gather patient insights for drug development. For instance, in November 2022, according to Statistics Canada, a Canada-based government agency, one-fourth (24%) of healthcare workers in Canada delivered healthcare services remotely since March 2020, with phone consultations being the most common method, followed by video calls and other digital platforms. Furthermore, in October 2022, according to the Centers for Disease Control and Prevention, a US-based government agency, in the year 2021, telemedicine was utilized by 37.0% of individuals, which increased with age and was more prevalent among women (42.0%) than among men (31.7%). Therefore, the expansion of telemedicine and remote patient monitoring is driving the growth of the pharma 4.0 market.

Key Industry Players
Major companies operating in the pharma 4.0 market are Alphabet Inc., Microsoft Corporation, Pfizer Inc., Johnson & Johnson, Amazon Web Services Inc. , Roche Holding AG, International Business Machines Corporation, Merck & Co. Inc., Cisco Systems Inc., Bristol Myers Squibb Company, Oracle Corporation, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline plc, Honeywell International Inc., Fujitsu Limited, ABB Ltd., Siemens Healthineers, GE Healthcare, Lotte Corporation, SAS Institute Inc., Optum Inc., POLARISqb, Syntekabio, Optibrium

The pharma 4.0 market report table of contents includes:
1. Executive Summary

2. Pharma 4.0 Market Characteristics

3. Pharma 4.0 Market Trends And Strategies

4. Pharma 4.0 Market - Macro Economic Scenario

5. Global Pharma 4.0 Market Size and Growth
.
32. Global Pharma 4.0 Market Competitive Benchmarking

33. Global Pharma 4.0 Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pharma 4.0 Market

35. Pharma 4.0 Market Future Outlook and Potential Analysis

36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model